3 completed, 2 withdrawn, 1 recruiting. 2 Phase 2, 2 Phase 3, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 2 | Recruiting 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow TCM Biotech International Corp.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects Placebo, 2 cap.LivPhcD/per day, 4 cap.LivPhcD/per day - NAFLD | Not applicable | Completed | TCM Biotech International Corp. | 110 | 2023-12-07 | 2026-10-02 |
| Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women U101, Placebo - Recurrent Urinary Tract Infections in Women | Phase 3 | Recruiting | TCM Biotech International Corp. | 348 | 2020-10-14 | 2026-10-02 |
| A Study of PTX-9908 Injection for Non-resectable HCC With TACE PTX-9908 Injection, Placebo - Carcinoma, Hepatocellular | Phase 1 / Phase 2 | Withdrawn | TCM Biotech International Corp. | 2020-10-06 | 2026-10-02 | |
| Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence Hepatocellular Carcinoma | Completed | TCM Biotech International Corp. | 207 | 2019-12-22 | 2024-04-10 | |
| The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III) Peginterferon alfa-2a, Ribavirin, TCM-700C - Chronic Hepatitis C | Phase 3 | Withdrawn | TCM Biotech International Corp. | 2015-06-01 | 2017-04-28 | |
| The Effects of Adding TCM-700C on the Standard Combination Treatment for Patients With Genotype 1 Hepatitis C Infection TCM-700C, Peginterferon alfa-2a, Ribavirin - Chronic Hepatitis C | Phase 2 | Completed | TCM Biotech International Corp. | 84 | 2007-07-01 | 2014-08-07 |
Carcinoma, Hepatocellular (2) · Hepatitis C, Chronic (2) · Hepatitis B (1) · Non-alcoholic Fatty Liver Disease (1) · Urinary Tract Infections (1)
Ribavirin (2) · peginterferon alfa-2a (2) · Pentosan Sulfuric Polyester (1) · peginterferon alfa-2b (1)
Taiwan (6) · China (1)
Chien-Hung Chien-Hung, MD, PhD (1) · En Meng, MD (1) · I-Sheen Sheen, MD (1) · I-Shyan Sheen, MD (1) · Lai Wei, MD (1) · Pei-Jer Chen, Ph.D (1)